Episode

Episode 192 - Sandeep Kulkarni - CEO Zura Bio

Podcast
The BioHub - by Avetix
Published
Jun 19, 2026
Duration seconds
1699
Processing state
not_requested
Canonical source
https://podcasters.spotify.com/pod/show/max-brennan4/episodes/Episode-192---Sandeep-Kulkarni---CEO-Zura-Bio-e3l0she
Audio
https://anchor.fm/s/f0076084/podcast/play/121712622/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-5-19%2F426455455-44100-2-0d6f6392023eb.mp3
JSON
/v1/public/podcasts/the-biohub-by-avetix-7252289/episodes/episode-192-sandeep-kulkarni-ceo-zura-bio
Markdown
/podcast/the-biohub-by-avetix-7252289/episode-192-sandeep-kulkarni-ceo-zura-bio.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-biohub-by-avetix-7252289/episodes/episode-192-sandeep-kulkarni-ceo-zura-bio/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-192-sandeep-kulkarni-ceo-zura-bio.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In this episode of The BioHub Podcast, Max sits down with Dr. Sandeep Kulkarni, Co-Founder and CEO of Zura Bio. Sandeep's career has spanned consulting, investing, and operating roles across biotech, including positions at BCG, Roivant, and Immunovant, before going on to co-found Tourmaline Bio and now lead Zura Bio. Zura is a clinical-stage biotechnology company focused on developing novel therapies for autoimmune and inflammatory diseases through a differentiated multi-asset strategy. In this conversation, we discuss Sandeep's journey into the CEO role, the thinking behind Zura's strategy, the lessons he's learned from building companies, and how founders should navigate today's biotech environment. We also explore company culture, portfolio building, and when founders should think about strategic exits versus building independently.